Literature DB >> 8910421

Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate.

H S Cheung1, I V Kurup, J D Sallis, L M Ryan.   

Abstract

Articular cartilage vesicles (ACV), isolated by differential centrifugation of adult hyaline articular cartilage collagenase digests, mineralized in the presence of calcium and ATP. Mineral analysis by microscopy, chemical analysis, energy-dispersive analysis, and infrared spectroscopy revealed crystals resembling calcium pyrophosphate dihydrate (CPPD). Adult articular cartilage also underwent ATP-dependent mineralization, supporting the contention that vesicles in situ fostered adult articular cartilage mineralization. Phosphocitrate (PC) is a recognized in vitro inhibitor of hydroxyapatite and calcium oxalate monohydrate crystal formation, but it is not known whether PC can similarly restrict CPPD crystal development. In the present study we examine the effect of PC, citrate, and n-sulfo-2-amino-tricarballylate (SAT, a PC analogue) on the ATP-induced CPPD crystal formation in both ACV and articular cartilage models. Only PC (10-1000 microM) blocked both the ATP-dependent and -independent mineralization in ACV in a dose-dependent fashion. At 1 mM, SAT and citrate blocked the ATP-independent mineralization. Similarly, only PC blocked both the ATP- and non-ATP-dependent mineralization in native articular cartilage slices. PC, SAT, and citrate had no effect on ACV nucleoside triphosphate pyrophosphohydrolase activity, suggesting that none of these agents blocked mineralization through the inhibition of nucleoside triphosphate pyrophosphohydrolase activity, which generates inorganic pyrophosphate from ATP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910421     DOI: 10.1074/jbc.271.45.28082

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  The role of crystals in articular tissue degeneration.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Molecular dynamics simulation studies of the effect of phosphocitrate on crystal-induced membranolysis.

Authors:  Pranav Dalal; Kimberly Zanotti; Andrzej Wierzbicki; Jeffry D Madura; Herman S Cheung
Journal:  Biophys J       Date:  2005-07-22       Impact factor: 4.033

3.  [Chondrocalcinosis. Clinical impact of intra-articular calcium phosphate crystals].

Authors:  M Fuerst
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

Review 4.  Phosphocitrate as a potential therapeutic strategy for crystal deposition disease.

Authors:  H S Cheung
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.592

Review 5.  Pathogenesis of cartilage calcification: mechanisms of crystal deposition in cartilage.

Authors:  Adele L Boskey
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

6.  New approaches in the detection of calcium-containing microcrystals in synovial fluid.

Authors:  Aaron Hernandez-Santana; Alexander Yavorskyy; Sinéad T Loughran; Geraldine M McCarthy; Gillian P McMahon
Journal:  Bioanalysis       Date:  2011-05       Impact factor: 2.681

Review 7.  Biomineralization of bone: a fresh view of the roles of non-collagenous proteins.

Authors:  Jeffrey Paul Gorski
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

Review 8.  The ank gene story.

Authors:  L M Ryan
Journal:  Arthritis Res       Date:  2000-12-19

9.  The Therapeutic Potential of Exogenous Adenosine Triphosphate (ATP) for Cartilage Tissue Engineering.

Authors:  Jenna Usprech; Gavin Chu; Renata Giardini-Rosa; Kathleen Martin; Stephen D Waldman
Journal:  Cartilage       Date:  2012-10       Impact factor: 4.634

10.  Articular cartilage mineralization in osteoarthritis of the hip.

Authors:  Martin Fuerst; Oliver Niggemeyer; Lydia Lammers; Fritz Schäfer; Christoph Lohmann; Wolfgang Rüther
Journal:  BMC Musculoskelet Disord       Date:  2009-12-29       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.